| Date of Action |
Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|---|---|
| May 09, 2024 |
print number 6084b |
| May 09, 2024 |
amend and recommit to consumer protection |
| Jan 03, 2024 |
referred to consumer protection |
| May 24, 2023 |
print number 6084a |
| May 24, 2023 |
amend and recommit to consumer protection |
| Mar 28, 2023 |
referred to consumer protection |
Senate Bill S6084A
2023-2024 Legislative Session
Sponsored By
(D) 34th Senate District
Archive: Last Bill Status - In Senate Committee Consumer Protection Committee
Actions
Bill Amendments
2023-S6084 - Details
- See Assembly Version of this Bill:
- A6506
- Current Committee:
- Senate Consumer Protection
- Law Section:
- General Business Law
- Laws Affected:
- Add §392-k, Gen Bus L
- Versions Introduced in 2025-2026 Legislative Session:
-
S7668, A1248
2023-S6084 - Sponsor Memo
BILL NUMBER: S6084
SPONSOR: FERNANDEZ
TITLE OF BILL:
An act to amend the general business law, in relation to prohibiting the
sale of xylazine
PURPOSE OR GENERAL IDEA OF BILL:
To prohibit the sale of xylazine without proof of its intended use for
institutional or scientific purposes.
SUMMARY OF PROVISIONS:
Section 1 prohibits the sale and delivery of xylazine in the State with-
out proof of its intended use for institutional or scientific purposes.
Section 2 sets the effective date.
JUSTIFICATION:
2023-S6084 - Bill Text download pdf
S T A T E O F N E W Y O R K
________________________________________________________________________
6084
2023-2024 Regular Sessions
I N S E N A T E
March 28, 2023
___________
Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when
printed to be committed to the Committee on Consumer Protection
AN ACT to amend the general business law, in relation to prohibiting the
sale of xylazine
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. The general business law is amended by adding a new section
392-k to read as follows:
§ 392-K. SALE OF XYLAZINE. 1. FOR PURPOSES OF THIS SECTION, THE TERM
"XYLAZINE" SHALL MEAN A PHARMACEUTICAL DRUG USED FOR SEDATION, ANES-
THESIA, MUSCLE RELAXATION, AND ANALGESIA IN ANIMALS SUCH AS HORSES,
CATTLE, AND OTHER NON-HUMAN MAMMALS.
2. NO PERSON, CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY,
FIRM, ONLINE PLATFORM, OR ANY OTHER BUSINESS ENTITY DOING BUSINESS WITH-
IN THIS STATE SHALL SELL, OFFER FOR SALE, OR DELIVER XYLAZINE TO INDI-
VIDUALS WITHOUT PROOF OF ITS INTENDED USE FOR INSTITUTIONAL OR SCIENTIF-
IC PURPOSES.
3. NO PERSON, CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY,
FIRM, ONLINE PLATFORM, OR OTHER BUSINESS ENTITY DOING BUSINESS WITHIN
THIS STATE SHALL SELL, OFFER FOR SALE, OR DELIVER XYLAZINE TO INDIVID-
UALS UNDER THE AGE OF TWENTY-ONE.
4. ANY PERSON, CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY,
FIRM, ONLINE PLATFORM OR OTHER BUSINESS ENTITY DOING BUSINESS WITHIN
THIS STATE WHICH SELLS, OFFERS FOR SALE, OR DISTRIBUTES XYLAZINE, SHALL
REQUIRE AND RETAIN SALES RECORDS, PROOF OF AGE, AND PROOF OF USE FROM
ALL PURCHASERS.
5. ANY INDIVIDUAL HARMED BY A VIOLATION OF THIS SECTION SHALL HAVE A
PRIVATE RIGHT OF ACTION FOR COMPENSATORY AND ACTUAL DAMAGES, PUNITIVE
DAMAGES, ATTORNEYS' FEES AND COSTS.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD10463-01-3
co-Sponsors
(D) 15th Senate District
2023-S6084A - Details
- See Assembly Version of this Bill:
- A6506
- Current Committee:
- Senate Consumer Protection
- Law Section:
- General Business Law
- Laws Affected:
- Add §392-k, Gen Bus L
- Versions Introduced in 2025-2026 Legislative Session:
-
S7668, A1248
2023-S6084A - Sponsor Memo
BILL NUMBER: S6084A
SPONSOR: FERNANDEZ
TITLE OF BILL:
An act to amend the general business law, in relation to prohibiting the
sale of xylazine
PURPOSE OR GENERAL IDEA OF BILL:
To prohibit the sale of xylazine without proof of its intended use for
institutional or scientific purposes.
SUMMARY OF PROVISIONS:
Section 1 prohibits the sale and delivery of xylazine in the State with-
out proof of its intended use for institutional or scientific purposes.
Subdivision 5 removes the private right of action and replaces it with a
civil penalty of up to $500 and additionally specifies that the drug may
be sold for veterinary purposes which is the main purpose of the drug.
Section 2 sets the effective date.
2023-S6084A - Bill Text download pdf
S T A T E O F N E W Y O R K
________________________________________________________________________
6084--A
2023-2024 Regular Sessions
I N S E N A T E
March 28, 2023
___________
Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when
printed to be committed to the Committee on Consumer Protection --
committee discharged, bill amended, ordered reprinted as amended and
recommitted to said committee
AN ACT to amend the general business law, in relation to prohibiting the
sale of xylazine
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. The general business law is amended by adding a new section
392-k to read as follows:
§ 392-K. SALE OF XYLAZINE. 1. FOR PURPOSES OF THIS SECTION, THE TERM
"XYLAZINE" SHALL MEAN A PHARMACEUTICAL DRUG USED FOR SEDATION, ANES-
THESIA, MUSCLE RELAXATION, AND ANALGESIA IN ANIMALS SUCH AS HORSES,
CATTLE, AND OTHER NON-HUMAN MAMMALS.
2. NO PERSON, CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY,
FIRM, ONLINE PLATFORM, OR ANY OTHER BUSINESS ENTITY DOING BUSINESS WITH-
IN THIS STATE SHALL SELL, OFFER FOR SALE, OR DELIVER XYLAZINE TO INDI-
VIDUALS WITHOUT PROOF OF ITS INTENDED USE FOR INSTITUTIONAL, VETERINARY,
OR SCIENTIFIC PURPOSES.
3. NO PERSON, CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY,
FIRM, ONLINE PLATFORM, OR OTHER BUSINESS ENTITY DOING BUSINESS WITHIN
THIS STATE SHALL SELL, OFFER FOR SALE, OR DELIVER XYLAZINE TO INDIVID-
UALS UNDER THE AGE OF TWENTY-ONE.
4. ANY PERSON, CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY,
FIRM, ONLINE PLATFORM OR OTHER BUSINESS ENTITY DOING BUSINESS WITHIN
THIS STATE WHICH SELLS, OFFERS FOR SALE, OR DISTRIBUTES XYLAZINE, SHALL
REQUIRE AND RETAIN SALES RECORDS, PROOF OF AGE, AND PROOF OF USE FROM
ALL PURCHASERS.
5. ANY PERSON, CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY,
FIRM, ONLINE PLATFORM, OR OTHER BUSINESS ENTITY DOING BUSINESS WITHIN
THIS STATE THAT VIOLATES THE PROVISIONS OF THIS SECTION BY SELLING,
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD10463-03-3
co-Sponsors
(D) 15th Senate District
2023-S6084B (ACTIVE) - Details
- See Assembly Version of this Bill:
- A6506
- Current Committee:
- Senate Consumer Protection
- Law Section:
- General Business Law
- Laws Affected:
- Add §392-k, Gen Bus L
- Versions Introduced in 2025-2026 Legislative Session:
-
S7668, A1248
2023-S6084B (ACTIVE) - Sponsor Memo
BILL NUMBER: S6084B
SPONSOR: FERNANDEZ
TITLE OF BILL:
An act to amend the general business law, in relation to prohibiting the
sale of xylazine
PURPOSE OR GENERAL IDEA OF BILL:
To prohibit the sale of xylazine without proof of its intended use for
institutional or scientific purposes.
SUMMARY OF PROVISIONS:
Section 1 prohibits the sale and delivery of xylazine in the State with-
out proof of its intended use for institutional or scientific purposes.
Section 2 sets the effective date.
JUSTIFICATION:
2023-S6084B (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K
________________________________________________________________________
6084--B
2023-2024 Regular Sessions
I N S E N A T E
March 28, 2023
___________
Introduced by Sens. FERNANDEZ, ADDABBO -- read twice and ordered print-
ed, and when printed to be committed to the Committee on Consumer
Protection -- committee discharged, bill amended, ordered reprinted as
amended and recommitted to said committee -- recommitted to the
Committee on Consumer Protection in accordance with Senate Rule 6,
sec. 8 -- committee discharged, bill amended, ordered reprinted as
amended and recommitted to said committee
AN ACT to amend the general business law, in relation to prohibiting the
sale of xylazine
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. The general business law is amended by adding a new section
392-k to read as follows:
§ 392-K. SALE OF XYLAZINE. 1. FOR PURPOSES OF THIS SECTION, THE TERM
"XYLAZINE" SHALL MEAN A PHARMACEUTICAL DRUG USED FOR SEDATION, ANES-
THESIA, MUSCLE RELAXATION, AND ANALGESIA IN ANIMALS SUCH AS HORSES,
CATTLE, AND OTHER NON-HUMAN MAMMALS.
2. NO CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY, FIRM,
ONLINE PLATFORM, OR ANY OTHER BUSINESS ENTITY DOING BUSINESS WITHIN THIS
STATE SHALL KNOWINGLY SELL, OFFER FOR SALE, OR DELIVER XYLAZINE TO INDI-
VIDUALS WITHOUT PROOF OF ITS INTENDED USE FOR INSTITUTIONAL, VETERINARY,
OR SCIENTIFIC PURPOSES.
3. NO CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY, FIRM,
ONLINE PLATFORM, OR OTHER BUSINESS ENTITY DOING BUSINESS WITHIN THIS
STATE SHALL KNOWINGLY SELL, OFFER FOR SALE, OR DELIVER XYLAZINE TO INDI-
VIDUALS UNDER THE AGE OF TWENTY-ONE.
4. ANY CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY, FIRM,
ONLINE PLATFORM OR OTHER BUSINESS ENTITY DOING BUSINESS WITHIN THIS
STATE WHICH KNOWINGLY SELLS, OFFERS FOR SALE, OR DISTRIBUTES XYLAZINE,
SHALL REQUIRE AND RETAIN SALES RECORDS, PROOF OF AGE, AND PROOF OF USE
FROM ALL PURCHASERS.
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD10463-06-4
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.